Success Metrics

Clinical Success Rate
60.0%

Based on 3 completed trials

Completion Rate
60%(3/5)
Active Trials
0(0%)
Results Posted
100%(3 trials)
Terminated
2(20%)

Phase Distribution

Ph not_applicable
3
30%
Ph phase_2
4
40%
Ph phase_1
2
20%

Phase Distribution

2

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
2(22.2%)
Phase 2Efficacy & side effects
4(44.4%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

42.9%

3 of 7 finished

Non-Completion Rate

57.1%

4 ended early

Currently Active

0

trials recruiting

Total Trials

10

all time

Status Distribution
Completed(3)
Terminated(4)
Other(3)

Detailed Status

Completed3
unknown3
Terminated2
Withdrawn2

Development Timeline

Analytics

Development Status

Total Trials
10
Active
0
Success Rate
60.0%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (22.2%)
Phase 24 (44.4%)
N/A3 (33.3%)

Trials by Status

completed330%
unknown330%
terminated220%
withdrawn220%

Recent Activity

0 active trials
Showing 5 of 10
terminatedphase_2

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

NCT00665457
terminatednot_applicable

MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma

NCT00756106
completedphase_2

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

NCT00564733
completedphase_2

Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers

NCT02099136
completedphase_1

MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery

NCT01098344
View all 10 trials

Clinical Trials (10)

Showing 10 of 10 trials
NCT00665457Phase 2

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Terminated
NCT00756106Not Applicable

MRI Scans in Evaluating the Effects of Radiation Therapy and Chemotherapy in Patients With Newly Diagnosed Glioblastoma Multiforme or Anaplastic Glioma

Terminated
NCT00564733Phase 2

FDG-Labeled PET Scan in Planning Chemotherapy in Treating Patients With Stage IIIB or IV Non-Small Cell Lung Cancer

Completed
NCT02099136Phase 2

Celecoxib in Preventing the Damaging Effects of Sunburn in Healthy Volunteers

Completed
NCT01098344Phase 1

MK0752 and Gemcitabine Hydrochloride in Treating Patients With Stage III and IV Pancreatic Cancer That Cannot Be Removed by Surgery

Completed
NCT00635245Phase 1

CP-751871 In Treating Women With Early-Stage Breast Cancer That Can Be Removed By Surgery

Withdrawn
NCT01222676Phase 2

Cisplatin, Gemcitabine Hydrochloride, and Sorafenib Tosylate in Treating Patients With Transitional Cell Cancer of the Bladder

Unknown
NCT01105364Not Applicable

Ultrasound in Assessing Antiangiogenic Treatment in Patients With Advanced Kidney Cancer

Unknown
NCT00796874Not Applicable

Magnetic Resonance Imaging in Detecting Cancer Progression in Patients With Early Stage Prostate Cancer Undergoing Active Surveillance

Withdrawn
NCT01666171

Studying Changes in Breast Density in Patients With Early-Stage Breast Cancer Treated With Metformin Hydrochloride or Placebo on CAN-NCIC-MA.32

Unknown

All 10 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
10